TipRanks
Advertisement
Advertisement

RNAC Stock Latest News

Cartesian Therapeutics announces positive retreatment data on Descartes-08
The FlyCartesian Therapeutics announces positive retreatment data on Descartes-08
9d ago
RNAC
Cartesian Therapeutics Reports Encouraging Descartes-08 Retreatment Data
PremiumCompany Announcements
Cartesian Therapeutics Reports Encouraging Descartes-08 Retreatment Data
9d ago
8K
RNAC
Cartesian Therapeutics: Late-Stage Descartes-08 De-Risking and 2027 Data Wave Underpin Van Buren’s Buy Rating
PremiumRatings
Cartesian Therapeutics: Late-Stage Descartes-08 De-Risking and 2027 Data Wave Underpin Van Buren’s Buy Rating
2M ago
RNAC
Buy Rating Reiterated on Strong Cash Runway and Near‑Term Clinical Catalysts; $40 Price Target Maintained
PremiumRatings
Buy Rating Reiterated on Strong Cash Runway and Near‑Term Clinical Catalysts; $40 Price Target Maintained
2M ago
RNAC
Cartesian Therapeutics Shareholders Back Directors and Governance Measures
PremiumCompany Announcements
Cartesian Therapeutics Shareholders Back Directors and Governance Measures
4M ago
8K
RNAC
Reiterating Buy on Cartesian: WestGene LNP Deal Expands In Vivo Pipeline and Catalyzes Long-Term Growth
PremiumRatingsReiterating Buy on Cartesian: WestGene LNP Deal Expands In Vivo Pipeline and Catalyzes Long-Term Growth
4M ago
RNAC
Selecta Biosciences Inc trading resumes
Premium
The Fly
Selecta Biosciences Inc trading resumes
4M ago
RNAC
Selecta Biosciences Inc trading halted, volatility trading pause
Premium
The Fly
Selecta Biosciences Inc trading halted, volatility trading pause
4M ago
RNAC
Cartesian Therapeutics Announces In Vivo CAR-T Licensing Alliance
PremiumCompany Announcements
Cartesian Therapeutics Announces In Vivo CAR-T Licensing Alliance
4M ago
8K
RNAC
Cartesian Therapeutics secures up to $150M financing from K2 HealthVentures
PremiumThe Fly
Cartesian Therapeutics secures up to $150M financing from K2 HealthVentures
4M ago
RNAC
Cartesian Secures Major Loan Facility to Extend Runway
PremiumCompany Announcements
Cartesian Secures Major Loan Facility to Extend Runway
4M ago
8K
RNAC
Cartesian Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
PremiumThe Fly
Cartesian Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
5M ago
RNAC
Cartesian Therapeutics management to meet with BTIG
PremiumThe FlyCartesian Therapeutics management to meet with BTIG
5M ago
RNAC
Buy Rating on Cartesian Therapeutics (RNAC) Driven by Strong Strategic Vision, Clinical Roadmap, and Attractive Risk‑Reward Profile
Premium
Ratings
Buy Rating on Cartesian Therapeutics (RNAC) Driven by Strong Strategic Vision, Clinical Roadmap, and Attractive Risk‑Reward Profile
6M ago
RNAC
Cartesian Therapeutics Announces Board Member Murat Kalayoglu Resignation
Premium
Company Announcements
Cartesian Therapeutics Announces Board Member Murat Kalayoglu Resignation
6M ago
8K
RNAC
RNAC’s Descartes-08 Moves Toward Phase 2 in Rare Muscle Disease: What Investors Should Watch
PremiumCompany Announcements
RNAC’s Descartes-08 Moves Toward Phase 2 in Rare Muscle Disease: What Investors Should Watch
7M ago
RNAC
Cartesian Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
PremiumThe Fly
Cartesian Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
7M ago
RNAC
Cartesian Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
PremiumThe Fly
Cartesian Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
7M ago
RNAC
Cartesian Therapeutics: Reaffirmed AURORA Timelines and Solid Cash Runway Underpin Needham Buy Rating and $42 Target
PremiumRatings
Cartesian Therapeutics: Reaffirmed AURORA Timelines and Solid Cash Runway Underpin Needham Buy Rating and $42 Target
7M ago
RNAC
Cartesian Therapeutics reports FY25 EPS ($5.02), consensus ($2.35)
PremiumThe FlyCartesian Therapeutics reports FY25 EPS ($5.02), consensus ($2.35)
7M ago
RNAC
RNAC Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
RNAC Upcoming Earnings Report: What to Expect?
7M ago
RNAC
Cartesian Therapeutics announces employment inducement grants
Premium
The Fly
Cartesian Therapeutics announces employment inducement grants
8M ago
RNAC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >